To test this hypothesis, mouse models were used in the Grimes and Möröy laboratories that develop diseases similar to T-ALL and B-ALL and in which Gfi1 could be deleted either constitutively or conditionally. This evidence concerns the gene GFI1 and acute lymphoblastic leukemia.